The Drug Enforcement Administration (DEA) has published two proposed regulations to address how telehealth may be used to prescribe controlled substances in a post-PHE environment. The DEA is proposing new exceptions that along with what is already in current law, will open up more ways for telehealth to be used to prescribe a controlled substance, but they are highly specific. At this point, these are only proposed rules, but the deadline to submit public comment is quickly approaching.  View the PPT here.